GPR35-KLF5 Circuit: Sensing and Repairing Colonic Epithelial
2026-04-19
GPR35-KLF5 Circuitry Orchestrates Colonic Epithelial Repair: Implications for Experimental Colitis Models
Study Background and Research Question
Ulcerative colitis (UC) is a chronic, relapsing inflammatory condition of the colon, characterized by persistent mucosal injury and impaired barrier repair. The loss of intestinal epithelial integrity, often modeled in mice using Dextran sulfate sodium salt (DSS, MW 35000-45000), is a central pathological event that initiates and perpetuates UC (internal_article_1). While the importance of epithelial repair—driven by the proliferation and migration of intestinal epithelial cells (IECs)—is well recognized, the molecular mechanisms enabling IECs to sense damage and execute precise repair programs have remained elusive (reference_paper).Key Innovation from the Reference Study
The study led by Xie et al. identifies a critical molecular circuit in IECs: the G protein-coupled receptor 35 (GPR35) serves as a metabolic gatekeeper, sensing damage-related shifts in tryptophan (Trp) metabolism—specifically, changes in the Trp-kynurenine (KYN)-kynurenic acid (KA) axis. Upon detecting elevated KA, GPR35 engages a unique 'sandwich' binding mode and activates Kruppel-like factor 5 (KLF5), which then orchestrates a PI3K-AKT-mTOR signaling cascade. This circuit enables IECs to decode mucosal injury signals and program a targeted repair response (reference_paper).Methods and Experimental Design Insights
To elucidate this signaling axis, the authors utilized both in vivo and in vitro approaches:- DSS-Induced Colitis: Mice were administered DSS (MW 35000-45000) in drinking water to induce acute colonic injury, modeling key features of human UC, including epithelial apoptosis, barrier disruption, and inflammation (internal_article_1).
- Genetic Manipulation: Gpr35 knockout and Klf5-deficient mice were generated to dissect the roles of these genes in epithelial repair.
- Metabolomic Profiling: Targeted analysis of Trp metabolites (Trp, KYN, KA) was performed to link metabolic shifts with signaling events.
- Cellular Assays: IEC proliferation and migration were assayed using EdU incorporation and wound healing models.
- Signaling Pathway Analysis: Activation of PI3K-AKT-mTOR was measured in IECs following KA stimulation.
Protocol Parameters
- chemical inducer of experimental colitis | 2.5–5% (w/w) DSS in drinking water | mouse model of inflammatory bowel disease | Recapitulates human-like acute and chronic colitis, enabling studies of epithelial injury and repair | product_spec
- colonic epithelial apoptosis induction | ≥2.5% DSS, 5–7 days | preclinical UC research | Reliable induction of epithelial injury and apoptosis to test repair mechanisms | product_spec
- Trp metabolite (KA) supplementation | 100 μM (in vitro IECs) | signaling pathway dissection | Mimics metabolic shifts observed during mucosal damage | reference_paper
- Gpr35 or Klf5 knockout | genetic model | mechanistic studies | Defines receptor and effector roles in repair | reference_paper
- workflow optimization | pilot titration of DSS concentration | all DSS colitis models | Adjusts for strain sensitivity and desired injury severity | workflow_recommendation
Core Findings and Why They Matter
The study reveals several pivotal insights:- Damage Sensing via Metabolism: IECs detect mucosal injury through altered Trp metabolism, with increased KA serving as a damage-associated signal (reference_paper).
- GPR35 as a Metabolic Gatekeeper: GPR35 binds KA in a structurally specific manner, acting as a molecular sensor on IECs. Genetic ablation of Gpr35 impairs damage signal decoding, resulting in defective repair.
- KLF5-Dependent Repair Programming: KLF5 is activated downstream of GPR35 and drives the expression of genes required for IEC proliferation and migration. Disrupting this circuit leads to delayed mucosal healing and worsened colitis.
- PI3K-AKT-mTOR Pathway Involvement: The GPR35-KLF5 axis signals through the PI3K-AKT-mTOR cascade, linking metabolic sensing to canonical cell survival and growth pathways.
Comparison with Existing Internal Articles
Several internal resources contextualize the practical value of DSS (MW 35000-45000) in modeling these repair processes:- "Dextran Sulfate Sodium Salt: Gold Standard for Experiment..." highlights DSS as a benchmark for reproducible mouse models of inflammatory bowel disease and details advanced applications for mucosal repair studies.
- "Dextran Sulfate Sodium Salt (MW 35000-45000): Reliable Mo..." provides scenario-driven guidance for designing and interpreting epithelial repair assays, emphasizing the importance of product quality and protocol optimization.
- "Dextran Sulfate Sodium Salt (MW 35000-45000): Decoding Ep..." elaborates on how DSS-induced damage models enable precise mechanistic studies of barrier disruption and repair, dovetailing with the present study's focus on molecular repair circuitry.
Limitations and Transferability
While the study provides compelling mechanistic insight, several limitations warrant consideration:- Species Differences: Although the DSS-induced mouse model of inflammatory bowel disease captures key features of human UC, interspecies differences in Trp metabolism and GPR35/KLF5 signaling may affect transferability to clinical settings (internal_article_1).
- Acute vs. Chronic Injury: The reference paper primarily addresses acute repair dynamics; chronic inflammation and repeated injury cycles may involve additional regulatory layers.
- Complexity of In Vivo Microenvironment: Factors such as microbiota composition and immune cell infiltration, both influenced by DSS treatment, could modulate the GPR35-KLF5 circuit in ways not fully captured by reductionist models.